Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NARD/Merck

Executive Summary

Retail pharmacy association "will no longer accept financial support from Merck," NARD Exec-VP West declares in April 4 letter. "Merck has increasingly initiated programs that will result in the demise of the independent retail pharmacist if not challenged," the letter states. Merck said it is "disappointed about the NARD decision and its mischaracterization" of the Merck Medicare pharmacy proposal. The Merck alternative "specifically pays any willing provider that meets pricing, professional and administrative terms and any pharmacy benefits manager may offer mail service but is not required to do so," the company said
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS024313

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel